Grand Venture 'well-poised' to gain across segments: DBS
Singapore
GRAND Venture Technology (GVT) is likely "well-poised" to gain from the positive industry outlook on all 3 of its segments, which includes the semiconductor, life sciences, and electronics and medical segments, said DBS Group Research.
The research team on Thursday (Apr 14) initiated coverage on the precision manufacturing company with a "buy" call and target price of S$1.50, as it assumes revenue will grow by 25 per cent in FY2022 and 22.5 per cent in FY2023.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China’s top airlines improve balance sheet in Q1; outlook positive for May Day
Stablecoin issuer Tether invests US$200 million in brain-computer interface company
Yahoo to lay off staff in Singapore as it shifts to content curation
US: Wall St opens higher on megacap strength, Fed verdict awaited
IReit Global occupancy rate grows to 91.5% in Q1
Yen surges against US dollar on suspected intervention